P3 Health Partners Inc.
PIII
$8.89
$0.222.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.50B | 1.48B | 1.40B | 1.35B | 1.27B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.50B | 1.48B | 1.40B | 1.35B | 1.27B |
| Cost of Revenue | 1.56B | 1.52B | 1.39B | 1.33B | 1.23B |
| Gross Profit | -58.92M | -40.20M | 8.73M | 21.56M | 31.64M |
| SG&A Expenses | 120.13M | 113.45M | 113.62M | 114.67M | 125.60M |
| Depreciation & Amortization | 86.06M | 86.54M | 86.59M | 86.67M | 86.68M |
| Other Operating Expenses | 53.70M | 12.43M | -18.23M | -16.85M | -12.71M |
| Total Operating Expenses | 1.82B | 1.73B | 1.58B | 1.52B | 1.43B |
| Operating Income | -318.80M | -252.62M | -173.25M | -162.94M | -167.93M |
| Income Before Tax | -305.99M | -249.14M | -179.56M | -179.11M | -183.73M |
| Income Tax Expenses | 4.39M | 1.20M | 5.22M | 4.48M | 2.70M |
| Earnings from Continuing Operations | -310.38 | -250.34 | -184.78 | -183.58 | -186.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 174.53M | 147.64M | 115.30M | 116.31M | 128.65M |
| Net Income | -135.85M | -102.69M | -69.48M | -67.27M | -57.77M |
| EBIT | -318.80M | -252.62M | -173.25M | -162.94M | -167.93M |
| EBITDA | -232.74M | -166.08M | -86.66M | -76.27M | -81.26M |
| EPS Basic | -51.77 | -37.67 | -29.13 | -29.29 | -32.49 |
| Normalized Basic EPS | -8.51 | -3.40 | 1.36 | 1.90 | 14.21 |
| EPS Diluted | -60.11 | -61.04 | -51.30 | -48.50 | -51.56 |
| Normalized Diluted EPS | -8.43 | -3.31 | 1.11 | 1.64 | 13.94 |
| Average Basic Shares Outstanding | 10.68M | 10.65M | 9.70M | 9.12M | 7.57M |
| Average Diluted Shares Outstanding | 10.83M | 10.80M | 13.76M | 13.09M | 11.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |